Hematological Malignancy: Clinical Trials

3 trials for Hematological Malignancy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 43Completed 3

Follow Hematological Malignancy: new trials by email Literature Review of Hematological Malignancy trials Research Report on Hematological Malignancy

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Short Versus Extended Antibiotic Treatment With a Carbapenem for High-risk Febrile Neutropenia in Hematology Patients With FUO
Discontinuation of imipenem-cilastatin or meropenem - Febrile Neutropenia, Hematological Malignancy
Phase 4CompletedAmsterdam UMC, location VUmc2762014-12-012019-09-25
The Effect of Special Diets in Hematological Cancer Patients
Special diet - Hematological Malignancy
Phase 4CompletedJens Rikardt Andersen322013-11-012016-08-29
A New Dosing Regimen for Posaconazole Prophylaxis in Children Based on Body Surface Area
Posaconazole prophylaxis 120 mg/m² tid, Blood sampling - Hematological Malignancy
Phase 4CompletedUniversitaire Ziekenhuizen KU Leuven142012-02-012015-03-03

Narrower conditions

Hematologic Neoplasms (3)  ·  Febrile Neutropenia (1)  ·  Fever (1)  ·  Neoplasms (1)  ·  Neutropenia (1)

Broader conditions

Hematologic Diseases (3)  ·  Hemic and Lymphatic Diseases (3)  ·  Neoplasms by Site (3)  ·  Neoplasms (2)  ·  Agranulocytosis (1)  ·  Body Temperature Changes (1)  ·  Cytopenia (1)  ·  Leukocyte Disorders (1)  ·  Leukopenia (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Signs and Symptoms (1)

Interventions

Blood Specimen Collection (1)  ·  Cilastatin, Imipenem Drug Combination (1)  ·  Meropenem (1)

Sponsors

Amsterdam UMC, location VUmc (1)  ·  Jens Rikardt Andersen (1)  ·  Universitaire Ziekenhuizen KU Leuven (1)

Countries

Belgium (1)  ·  Denmark (1)  ·  Netherlands (1)  ·  Romania (1)

Top investigators

Anca Colita, MD (1)  ·  Jens Rikardt Andersen, MD,MPA (1)  ·  Kim Vanstraelen, PharmD (1)  ·  Mark MH Kramer, Prof., MD (1)  ·  Michiel A van Agtmael, MD, PhD (1)  ·  Sonja Zweegman, Prof.,MD (1)

Results publications

PMID 35691326, PMID 39115709

NIH funding

2014 (1)